<ENAMEX TYPE="ORGANIZATION">Ciba-Geigy AG</ENAMEX>, the big Swiss chemicals company, said that it agreed in a letter of intent with <ENAMEX TYPE="ORGANIZATION">Corning Inc.</ENAMEX> to acquire <ENAMEX TYPE="ORGANIZATION">Corning</ENAMEX>'s 50% share of <ENAMEX TYPE="ORGANIZATION">Ciba Corning Diagnostics Corp.</ENAMEX>, based in <ENAMEX TYPE="LOCATION">Medfield</ENAMEX>, <ENAMEX TYPE="LOCATION">Mass.</ENAMEX>
<ENAMEX TYPE="ORGANIZATION">Ciba Corning</ENAMEX>, which had been a 50-50 venture between <ENAMEX TYPE="LOCATION">Basel</ENAMEX>-based <ENAMEX TYPE="ORGANIZATION">Ciba-Geigy</ENAMEX> and <ENAMEX TYPE="ORGANIZATION">Corning</ENAMEX>, has annual sales of about $300 million, the announcement said. Terms of the transaction weren't disclosed. <ENAMEX TYPE="ORGANIZATION">Ciba Corning</ENAMEX> makes clinical diagnostics systems and related products for the medical-care industry.
The announcement said the acquisition should be completed by December after a definitive agreement is completed and regulatory approval is received.
<ENAMEX TYPE="ORGANIZATION">Ciba-Geigy</ENAMEX> intends to develop the <ENAMEX TYPE="ORGANIZATION">Ciba Corning</ENAMEX> unit into a ``substantial business,'' making the unit an ``integral part'' of <ENAMEX TYPE="ORGANIZATION">Ciba-Geigy</ENAMEX>'s ``comprehensive disease management concept.
